Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | complement component 5a receptor 1 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Echinococcus multilocularis | G-protein coupled receptor, putative | complement component 5a receptor 1 | 350 aa | 293 aa | 22.2 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.0093 | 0.0844 | 0.0844 |
Loa Loa (eye worm) | hypothetical protein | 0.0324 | 0.7987 | 0.7987 |
Entamoeba histolytica | PH domain containing protein kinase, putative | 0.0163 | 0.303 | 1 |
Trichomonas vaginalis | AGC family protein kinase | 0.0065 | 0 | 0.5 |
Loa Loa (eye worm) | AGC/PKC/ALPHA protein kinase | 0.01 | 0.1069 | 0.1069 |
Echinococcus granulosus | RNA directed DNA polymerase | 0.0093 | 0.0844 | 0.1278 |
Trichomonas vaginalis | AGC family protein kinase | 0.0065 | 0 | 0.5 |
Echinococcus multilocularis | serine threonine protein kinase | 0.0164 | 0.3039 | 0.4601 |
Toxoplasma gondii | AGC kinase | 0.0065 | 0 | 0.5 |
Echinococcus multilocularis | Protein kinase C, brain isozyme | 0.021 | 0.4462 | 0.6756 |
Echinococcus granulosus | protein kinase c iota type | 0.0111 | 0.1423 | 0.2155 |
Echinococcus granulosus | Protein kinase C brain isozyme | 0.021 | 0.4462 | 0.6756 |
Trichomonas vaginalis | AGC family protein kinase | 0.0065 | 0 | 0.5 |
Brugia malayi | protein kinase C II. | 0.0279 | 0.6605 | 1 |
Trichomonas vaginalis | AGC family protein kinase | 0.0065 | 0 | 0.5 |
Echinococcus multilocularis | protein kinase c iota type | 0.0111 | 0.1423 | 0.2155 |
Echinococcus multilocularis | RNA directed DNA polymerase | 0.0093 | 0.0844 | 0.1278 |
Loa Loa (eye worm) | hypothetical protein | 0.0324 | 0.7987 | 0.7987 |
Trypanosoma brucei | rac serine-threonine kinase, putative | 0.0065 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0139 | 0.2267 | 0.2267 |
Schistosoma mansoni | serine/threonine protein kinase | 0.021 | 0.4462 | 0.6756 |
Echinococcus multilocularis | telomerase reverse transcriptase subunit | 0.0093 | 0.0844 | 0.1278 |
Trichomonas vaginalis | AGC family protein kinase | 0.0065 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.037 | 0.941 | 0.941 |
Loa Loa (eye worm) | AGC/PKC/ETA protein kinase | 0.0279 | 0.6605 | 0.6605 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0279 | 0.6605 | 1 |
Echinococcus granulosus | serine:threonine protein kinase N2 | 0.0163 | 0.303 | 0.4588 |
Onchocerca volvulus | 0.0324 | 0.7987 | 0.5 | |
Loa Loa (eye worm) | hypothetical protein | 0.0324 | 0.7987 | 0.7987 |
Schistosoma mansoni | atypical protein kinase C | 0.0111 | 0.1423 | 0.2155 |
Trichomonas vaginalis | AGC family protein kinase | 0.0065 | 0 | 0.5 |
Trichomonas vaginalis | AGC family protein kinase | 0.0065 | 0 | 0.5 |
Echinococcus multilocularis | serine:threonine protein kinase N2 | 0.0227 | 0.5 | 0.757 |
Trichomonas vaginalis | AGC family protein kinase | 0.0065 | 0 | 0.5 |
Trichomonas vaginalis | AGC family protein kinase | 0.0065 | 0 | 0.5 |
Echinococcus granulosus | protein kinase c epsilon type | 0.0279 | 0.6605 | 1 |
Schistosoma mansoni | serine/threonine protein kinase | 0.021 | 0.4462 | 0.6756 |
Trichomonas vaginalis | AGC family protein kinase | 0.0065 | 0 | 0.5 |
Echinococcus granulosus | protein kinase C gamma type | 0.0164 | 0.3039 | 0.4601 |
Brugia malayi | Protein kinase c protein 2 | 0.0146 | 0.2493 | 0.3774 |
Trichomonas vaginalis | AGC family protein kinase | 0.0065 | 0 | 0.5 |
Echinococcus multilocularis | protein kinase c epsilon type | 0.0279 | 0.6605 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 2 nM | BindingDB_Patents: FLIPR Assay. Compounds were tested for their ability to inhibit C5a-mediated calcium mobilization using a stable cell line over expressing the human C5aR & the Galpha 15 protein on the FLIPR (Fluorescent Imaging Plate Reader) Tetra system. Cells were maintained in culture media containing DMEM (Dulbecco's Modified Eagle Medium) with 4.5 g/L glucose, 10% fetal bovine serum, 100 U/mL, 1x non-essential amino acid, and 250 ug/mL G418 (Geneticin). Prior to testing of compounds, cells were plated at 10,000 cells/well in clear bottom 384-well black plate, and incubated overnight at 37C. with 5% CO2. On the day of experiment, culture media was removed, and replaced with assay buffer HBSS (Hanks' Balanced Salt Solution) with 20 mM HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) and 0.1% BSA (bovine serum albumin) BSA containing calcium 5 dye (Molecular Devices) and 2.5 mM probenecid. After 1 hour incubation at 37C., 5% CO2 for 60 min, cells were pre-incubated with compounds for 30 minutes. | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.